101 related articles for article (PubMed ID: 18630511)
1. Targeting of CDC20 via small interfering RNA causes enhancement of the cytotoxicity of chemoradiation.
Taniguchi K; Momiyama N; Ueda M; Matsuyama R; Mori R; Fujii Y; Ichikawa Y; Endo I; Togo S; Shimada H
Anticancer Res; 2008; 28(3A):1559-63. PubMed ID: 18630511
[TBL] [Abstract][Full Text] [Related]
2. Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells.
Tsuji N; Asanuma K; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2005; 25(6B):3967-72. PubMed ID: 16309185
[TBL] [Abstract][Full Text] [Related]
3. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells.
Hata T; Furukawa T; Sunamura M; Egawa S; Motoi F; Ohmura N; Marumoto T; Saya H; Horii A
Cancer Res; 2005 Apr; 65(7):2899-905. PubMed ID: 15805292
[TBL] [Abstract][Full Text] [Related]
4. CDC20, a potential cancer therapeutic target, is negatively regulated by p53.
Kidokoro T; Tanikawa C; Furukawa Y; Katagiri T; Nakamura Y; Matsuda K
Oncogene; 2008 Mar; 27(11):1562-71. PubMed ID: 17873905
[TBL] [Abstract][Full Text] [Related]
5. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of hTERT by SiRNA suppresses growth of Capan-2 human pancreatic cancer cell via the inhibition of expressions of Bcl-2 and COX-2.
Zhong YQ; Xia ZS; Fu YR; Zhu ZH
J Dig Dis; 2010 Jun; 11(3):176-84. PubMed ID: 20579221
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated siRNA targeting Mcl-1 gene increases radiosensitivity of pancreatic carcinoma cells in vitro and in vivo.
Guoan X; Hanning W; Kaiyun C; Hao L
Surgery; 2010 Apr; 147(4):553-61. PubMed ID: 20004446
[TBL] [Abstract][Full Text] [Related]
8. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.
Weiss FU; Marques IJ; Woltering JM; Vlecken DH; Aghdassi A; Partecke LI; Heidecke CD; Lerch MM; Bagowski CP
Gastroenterology; 2009 Dec; 137(6):2136-45.e1-7. PubMed ID: 19747919
[TBL] [Abstract][Full Text] [Related]
10. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
Gong M; Lu Z; Fang G; Bi J; Xue X
Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
[TBL] [Abstract][Full Text] [Related]
11. MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth.
Yuan Z; Liu X; Wong S; Machan JT; Chung MA
J Surg Res; 2009 Nov; 157(1):e39-46. PubMed ID: 19482310
[TBL] [Abstract][Full Text] [Related]
12. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines.
Fukumoto A; Tomoda K; Yoneda-Kato N; Nakajima Y; Kato JY
FEBS Lett; 2006 Oct; 580(25):5836-44. PubMed ID: 17027978
[TBL] [Abstract][Full Text] [Related]
13. [Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3].
Xu J; Liu C; Yu XJ; Jin C; Fu DL; Ni QX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1948-51. PubMed ID: 19062732
[TBL] [Abstract][Full Text] [Related]
14. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2.
Fang L; Hu Q; Hua Z; Li S; Dong W
Int J Oral Maxillofac Surg; 2008 Sep; 37(9):847-52. PubMed ID: 18620845
[TBL] [Abstract][Full Text] [Related]
16. The ABCC4 gene is a promising target for pancreatic cancer therapy.
Zhang Z; Wang J; Shen B; Peng C; Zheng M
Gene; 2012 Jan; 491(2):194-9. PubMed ID: 21989485
[TBL] [Abstract][Full Text] [Related]
17. Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen.
Morgan-Lappe SE; Tucker LA; Huang X; Zhang Q; Sarthy AV; Zakula D; Vernetti L; Schurdak M; Wang J; Fesik SW
Cancer Res; 2007 May; 67(9):4390-8. PubMed ID: 17483353
[TBL] [Abstract][Full Text] [Related]
18. Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.
Aleku M; Schulz P; Keil O; Santel A; Schaeper U; Dieckhoff B; Janke O; Endruschat J; Durieux B; Röder N; Löffler K; Lange C; Fechtner M; Möpert K; Fisch G; Dames S; Arnold W; Jochims K; Giese K; Wiedenmann B; Scholz A; Kaufmann J
Cancer Res; 2008 Dec; 68(23):9788-98. PubMed ID: 19047158
[TBL] [Abstract][Full Text] [Related]
19. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
Gan PP; Kavallaris M
Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
[TBL] [Abstract][Full Text] [Related]
20. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
